Short answer
agilon health, inc. (AGL) filed an 8-K current report with the SEC on November 16, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Virtual investor event scheduled for November 17, 2026 at 2:00 PM Eastern.
agilon health, inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Virtual investor event scheduled for November 17, 2026 at 2:00 PM Eastern
- Presentation webcast available through agilon health’s investor relations website
- Investor presentation furnished as Exhibit 99.1, with replay available after the event
Item EX-99.1 · Exhibit EX-99.1
- Investor presentation outlines agilon’s technology-enabled Total Care Model, emphasizing clinical pathways, physician engagement and quality programs
- Platform scale: ~30 markets, ~2,200 primary care physicians, 500K+ Medicare patients and ~$6B managed medical expense as of December 31, 2025
- Technology infrastructure includes 200M+ clinical documents, 700M+ lab results, 150M+ claims, 65+ payor connections and 120+ EMR integrations through September 17, 2026
- Clinical pathways target heart failure, dementia, serious illness care and other chronic conditions to reduce avoidable utilization and improve quality outcomes
- Presentation highlights execution and scalability, but also exposes investors to technology, clinical, reimbursement, leadership-transition and medical-cost risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other agilon health, inc. 8-K filings
Get the next AGL 8-K as it lands
Follow AGL for push alerts, or ask the research agent what this filing means.